Solar panel manufacturer First Solar (NASDAQ: FSLR) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 23.6% year on year to $1.04 billion. On the other hand, the company’s full-year revenue guidance of $5.05 billion at the midpoint came in 3.2% below analysts’ estimates. Its non-GAAP profit of $3.22 per share was 13.8% above analysts’ consensus estimates.

Is now the time to buy FSLR? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

First Solar began 2026 with strong operational execution, as management credited the quarter’s growth to record sales in India, the successful launch of its CURE technology at the Perrysburg facility, and margin expansion driven by cost reductions and U.S. manufacturing benefits. CEO Mark Widmar emphasized that the company’s differentiated cadmium telluride (CdTe) technology and domestic manufacturing footprint allowed First Solar to capitalize on both U.S. and Indian market demand. Widmar also noted that lower freight and warehouse costs contributed to profitability, and highlighted the importance of the company’s selective approach to booking new U.S. contracts while awaiting regulatory clarity.

Looking ahead, First Solar’s full-year guidance is shaped by regulatory developments, rollout of next-generation products, and evolving trade policy. Management remains focused on scaling CURE technology across its production fleet, with the majority of technology-driven revenue benefits expected to materialize in 2027 and 2028. CFO Alexander Bradley highlighted that decisions regarding Section 232 tariffs and domestic content requirements are likely to impact both customer demand and production strategies. Widmar stated, “We will remain disciplined in bookings as we await clarity from current policy and regulatory matters,” reflecting an ongoing wait-and-see approach amid policy uncertainty.

Key Insights from Management’s Remarks

Management attributed quarterly performance to the combination of new technology launches, increased sales volume in India, and cost optimization in U.S. operations.

• India market momentum: First Solar achieved record sales in India, supported by both utility-scale and agricultural demand for its CdTe modules, which are valued for their energy yield in hot climates. Management cited domestic content requirements and policy frameworks as key factors underpinning near-term demand.

• CURE technology rollout: The company completed the launch of its CURE technology in Perrysburg, Ohio, and began ramping production on its first Series 6 line. CURE offers up to 8% more lifetime energy production than comparable crystalline silicon modules, with full fleet adoption planned through 2028.

• U.S. manufacturing advantage: First Solar’s U.S. facilities operated at high utilization rates, and the upcoming South Carolina finishing plant is expected to optimize freight, tariff, and domestic content outcomes while benefiting from Section 45X tax credits for module assembly.

• Cost reduction initiatives: Lower freight and warehouse expenses contributed to six percentage points of gross margin expansion year over year. The company also reduced warehouse costs by $22 million from the prior quarter, as part of a plan to rationalize $100 million in costs by 2027.

• Policy and IP developments: Management highlighted ongoing enforcement actions to protect its intellectual property, including a Section 337 investigation at the U.S. International Trade Commission targeting imported TOPCon modules. Trade policy developments and regulatory decisions remain critical to future market dynamics and pricing.

Drivers of Future Performance

First Solar’s outlook for the remainder of the year depends on regulatory outcomes, technology ramp-up, and evolving customer mix, especially between U.S. and international markets.

• Trade policy uncertainty: Management emphasized that decisions on Section 232 tariffs and possible minimum import prices will shape both demand and pricing in the U.S. market. The company is maintaining flexibility in Southeast Asian production until policy clarity emerges, which could spur or suppress demand for non-U.S. modules.

• CURE and perovskite expansion: The company expects CURE technology adoption to drive higher energy yield and technology-based revenue adjustments over time. Additionally, a perovskite pilot line is planned for 2027, with management focused on validating field durability and performance before scaling.

• India and U.S. demand balance: Sustained demand in India is expected to keep local facilities at full utilization, while customer bookings in the U.S. remain selective until regulatory clarity returns. Management cautioned that shifts in domestic content rules or efficiency standards in India could affect future sales strategies.

Catalysts in Upcoming Quarters

In the coming quarters, StockStory analysts will monitor (1) the pace of CURE technology adoption and its impact on customer bookings, (2) outcomes of key U.S. trade policy decisions such as Section 232 tariffs and minimum import prices, and (3) continued strength in India and the ability to maintain high utilization at local facilities. Progress on the perovskite pilot line and any shifts in domestic content requirements will also be closely watched.

First Solar currently trades at $201.88, up from $197.70 just before the earnings. In the wake of this quarter, is it a buy or sell? The answer lies in our full research report (it’s free).

Now Could Be The Perfect Time To Invest In These Stocks

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.